References
1. Mehta S., Gupta B. Recurrent Pregnancy Loss. Singapore: Springer, 2018.
2. Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012; 98: 1103–11.
3. Eshre Guideline Group on RPL; Bender Atik R., Christiansen O.B., Elson J., Kolte A.M., Lewis S., Middeldorp S., et al. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2018; 2: 1–12.
4. Lachmi-Epstein A., Mazor M., Bashiri A. Psychological and mental aspects and «tender loving care» among women with recurrent pregnancy losses. Harefuah. 2012; 151: 633–37.
5. Rasmark Roepke E., Hellgren M., Hjertberg R., Blomqvist L., Matthiesen L., Henic E., et al. Treatment efficacy for idiopathic recurrent pregnancy loss – a systematic review and meta-analyses. Acta Obstet Gynecol Scand. 2018; 97: 921–41.
6. Szekeres-Bartho J., Balasch J. Progestagen therapy for recurrent miscarriage. Hum Reprod Update. 2008; 14: 27–35.
7. Shah D., Nagarajan N. Luteal insufficiency in first trimester. Indian J Endocrinol Metab. 2013; 17: 44–9.
8. Di Renzo G.C., Giardina I., Clerici G., Brillo E., Gerli S. Progesterone in normal and pathological pregnancy. Horm Mol Biol Clin Investig. 2016; 27: 35–48.
9. El-Zibdeh M.Y. Dydrogesterone in the reduction of recurrent spontaneous abortion. J Steroid Biochem Mol Biol. 2005; 97: 431–4.
10. Kumar A., Begum N., Prasad S., Aggarwal S., Sharma S. RETRACTED: oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial. Fertil Steril. 2014; 102 (5): 1357–63.e3. DOI: https://doi.org/10.1016/j.fertnstert.2014.07.1251
11. Mirza F.G., Patki A., Pexman-Fieth C. Dydrogesterone use in early pregnancy. Gynecol Endocrinol. 2016; 32: 97–106.
12. Saccone G., Schoen C., Franasiak J.M., Scott R.T. Jr, Berghella V. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials. Fertil Steril. 2017; 107: 430–8.e3.
13. Haas D.M., Ramsey P.S. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 2013; 31: CD003511.
14. Coomarasamy A., Williams H., Truchanowicz E., Seed P.T., Small R., Quenby S., et al. A randomized trial of progesterone in women with recurrent miscarriages. N Engl J Med. 2015; 373: 2141–8.
15. Druckmann R., Druckmann M.A. Progesterone and the immunology of pregnancy. J Steroid Biochem Mol Biol. 2005; 97: 389–96.
16. Bashiri A., Harlev A., Agarwal A. Recurrent Pregnancy Loss: Evidence-Based Evaluation, Diagnosis and Treatment. Cham: Springer International Publishing, 2016.
17. Jaslow C.R., Carney J.L., Kutteh W.H. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril. 2010; 93: 1234–43.
18. Ford H.B., Schust D.J. Recurrent pregnancy loss: Etiology, diagnosis, and therapy. Rev Obstet Gynecol. 2009; 2: 76–83.